Pharmacokinetics, metabolism and drug-abuse potential of nabilone
- 31 December 1982
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 9, 17-23
- https://doi.org/10.1016/s0305-7372(82)80031-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The stereoselective enzymic reduction of the synthetic 9-ketocannabinoid, nabilone,in vivo, in isolated liver cells and in liver homogenateXenobiotica, 1980
- Physiologic disposition of nabilone, a cannabinol derivative, in manClinical Pharmacology & Therapeutics, 1977
- Clinical pharmacology of nabilone, a cannabinol derivativeClinical Pharmacology & Therapeutics, 1975
- Pharmacologic effects and physiologic disposition of delta6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in manClinical Pharmacology & Therapeutics, 1974
- 11-Hydroxy-Δ 9 -tetrahydrocannabinol: Pharmacology, Disposition, and Metabolism of a Major Metabolite of Marihuana in ManScience, 1972
- METABOLISM AND DISPOSITION OF TETRAHYDROCANNABINOLS IN NÄIVE SUBJECTS AND CHRONIC MARIJUANA USERSAnnals of the New York Academy of Sciences, 1971
- Marihuana: Studies on the Disposition and Metabolism of Delta-9-Tetrahydrocannabinol in ManScience, 1970